Objectives: Dyspepsia is defined as persistent or recurrent abdominal pain or discomfort centered in the upper abdomen. Dyspepsia represents up to 8.3% of all primary care physician visits and causes huge economic costs to patients and to the economy as a whole. The aim of this study was to measure the influence of dyspepsia on work productivity of people within the Brazilian workforce. Methods: Adult patients were enrolled if they met the Roma III criteria for uninvestigated dyspepsia. All patients answered a demographic questionnaire. Productivity impairment was measured by the Work Productivity and Activity Impairment questionnaire. Subjects underwent upper gastrointestinal endoscopy and were classified as having functional or organic dyspepsia. The study protocol was approved by the Ethics Committee of Hospital de Clínicas de Porto Alegre, Brazil. Results: Eight hundred fifty patients with dyspepsia were evaluated: 628 were women (73.9%); mean age was 46.4 Ϯ 12.9 years; 387 (45.5%) were active workers.
Introduction
Symptoms of dyspepsia affect up to 40% of the adult population in the Western world [1] [2] [3] . According to the Rome III Consensus, diagnosis of dyspepsia is established if patients report at least one episode per week of epigastric pain or discomfort (postprandial fullness or early satiety) during the past three months. Symptoms must be present for more than six months. Most affected individuals do not have structural or biochemical abnormalities that can explain their symptoms and thus are classified as having functional or nonulcer dyspepsia [4, 5] . The most common organic causes are gastroesophageal reflux disease, peptic ulcer disease, and gastric cancer. Another important category is uninvestigated dyspepsia, which consists of dyspeptic symptoms previous to diagnostic investigation.
Dyspepsia accounts for 8.3% of visits to primary care physicians [6] , although more than half of these patients do not seek medical assistance [7] . Drugs prescribed predominantly for dyspepsia made up 7% of the primary care prescribing budget in the United Kingdom in 2004. The indirect costs are even more impressive. The reduction in quality of life is similar to that seen in patients with mild heart failure [8] . Dyspepsia can be severe enough to cause sick leave from work (absenteeism), as well as jeopardize productivity while working (presenteeism). In Sweden, a study [7] estimated the influence of dyspepsia, gastroesophageal reflux disease, and peptic ulcer disease on the budget of that country. Using a top-down approach, the study found that 1.9% of all costs from sick leave from work in Sweden was attributed to dyspepsia, corresponding to US$144 million in 1997. The coding system was not able to differentiate among dyspepsia, peptic ulcer disease, and gastroesophageal reflux disease as the cause of the absenteeism [7] . Another Swedish study [9] found that the average functional dyspepsia patient was responsible for 26 more days of lost production than the average employee without functional dyspepsia. In the Leeds HELP study [8] , conducted in the United Kingdom, 2% of 8473 randomly selected primary-care patients reported taking time off work because of dyspepsia, costing society annually £17.91 per person. Brook et al. [10] objectively measured the productivity of blue-collar workers and found that employees with functional dyspepsia produced 12% fewer units per hour than controls. A prospective study of dyspepsia from Southern General Hospital in Glasgow, Scotland [11] , showed that each employed patient with functional dyspepsia loses on average 18.3 weeks of work per year.
Although dyspepsia is very prevalent, the effect of dyspepsia on work absenteeism and presenteeism has not been assessed with validated tools. The influence of gastroesophageal reflux disease on work has been extensively studied, showing significant effects in patients with moderate to severe disease [12] [13] [14] , but there is a lack of similar information for patients with functional dyspepsia.
The aim of this study was to evaluate the influence of dyspepsia on work absenteeism, presenteeism, and productivity in daily life and to explore effect modifiers for the relationship between dyspepsia and productivity costs such as demographic data, severity of symptoms, and etiologic categories of dyspepsia.
Study design
This was a secondary study nested in the screening phase of the Helicobacter Eradication Relief of Dyspeptic Symptoms (HEROES) trial. HEROES trial was a randomized double-blind placebo-controlled clinical trial (ClinicalTrials.gov No. NCT00404534) carried out in a single academic hospital, the Hospital de Clínicas de Porto Alegre in Rio Grande do Sul, Brazil. The protocol was approved by the local institutional review board. Written informed consent was obtained from all patients before enrollment.
Patients
Primary care patients were recruited through newspaper, radio, and television advertising as well as through primary care clinic referrals. Patients of either sex were enrolled in the study if they were aged 18 years or older and had a diagnosis of dyspepsia according to the Roma III criteria. The symptoms must have been present for more than six months, with at least one episode per week of epigastric pain or burning or discomfort (postprandial fullness or early satiety) during the past three months.
Exclusion criteria included predominant symptoms of heartburn or irritable bowel syndrome; alarm symptoms (weight loss Ͼ 10% of the previous weight, anemia, bleeding, or positive physical examination findings suggesting organic disease); history of peptic ulcer, upper gastrointestinal surgery, or biliary colic; relevant comorbidities; and alcohol or drug abuse. We also excluded patients unable to answer the study questionnaires.
Outcomes measures
Data on health-related reduction in work absenteeism and productivity while at work and when performing daily activities were obtained using the generic version of the Work Productivity and Activity Impairment (WPAI) Questionnaire. The WPAI has six questions regarding if the person is currently employed, questions regarding hours absent from work for health reasons, hours absent from work for other reasons, and number of hours worked and questions evaluating the influence of health problems on productivity at work and at daily activities. It has a validated Brazilian Portuguese version shown to be a reliable and valid tool to measure the influence of health problems on productivity [15] .
The dyspeptic symptoms score was evaluated by trained investigators using the Porto Alegre Dyspeptic Symptoms Questionnaire (PADYQ) [16, 17] . This 11-question instrument assesses the frequency, duration, and intensity of dyspepsia symptoms during the preceding 30 days. Score ranges from 0 (no symptoms) to 44 (severe symptoms) and were validated in Brazilian Portuguese, showing high levels of internal consistency, reproducibility, responsiveness, face validity, discriminant validity, and concurrent validity.
Study procedures
Patients self-completed the WPAI questionnaire during the screening visit of the HEROES trial. After that, patients consulted with a trained investigator and provided demographic and clinical data, including information for the PADYQ questionnaire. Upper gastrointestinal endoscopies were performed at screening by two endoscopists. According to endoscopic findings, patients were classified into two etiologic subgroups: organic dyspepsia (if reflux esophagitis, peptic ulcer, celiac disease, malignancy, or achalasia was diagnosed) or functional dyspepsia.
Statistical methods
WPAI answers were computed to produce four scores: percentage of work missed for dyspepsia symptoms (absenteeism); percentage impairment at work for dyspepsia symptoms (presenteeism); the lost work productivity score (summarizing absenteeism and presenteeism) and impairment of daily activities due to dyspepsia. Absenteeism was calculated as the number of hours absent from work divided by the total work hours (total work hours ϭ hours absent from work ϩ hours actually worked) multiplied by 100, whereas presenteeism was calculated as the number of hours worked multiplied by the percentage reduction in productivity. The lost work productivity score was calculated as the sum of hours absent from work and reduced productivity at work (presenteeism) divided by the total work hours multiplied by 100. The percentage reduction in daily activities was used to measure impairment of daily activities due health related problems.
The lost work productivity score was transformed in monetary values multiplying the score by the median income per capita, published by the Brazilian Institute of Geography and Statistics. The values are shown in American dollars, using the exchange rate of July 1, 2010 ($1 ϭ 1.8 BRL).
Continuous variables were expressed as means and standard deviations and were analyzed using the t test for independent samples. Qualitative variables were expressed as percentages and were compared using Fisher's exact test. All two-tailed P values less than 0.05 were considered statistically significant. All variables that had P values that were less than 0.20 on univariate analysis were included in a forward stepwise logistic regression to assess their affect on the absenteeism, presenteeism, and daily activities. Correlation of dyspepsia and influence on work productivity was calculated with Spearman's rank correlation coefficient. All analyses were performed using PASW Statistics (version 18.0. 2009, SPSS Inc., Chicago, IL).
Results

Patients
Overall, 1151 screening visits were performed, and 850 patients fulfilled Rome III criteria for uninvestigated dyspepsia and were included in the study. Sixteen patients refused to undergo endoscopy and could not have their underlying etiology defined. The mean age of the included patients was 46.4 Ϯ 12.9 years and 73.9% were women. Overall, 45.5% (387 out of 850) of the study population was employed. Among patients with functional dyspepsia and organic dyspepsia 48.2% and 44.4% were employed, respectively (P ϭ 0.37). Other demographic data are shown in Table 1 .
Impact of dyspepsia on productivity
Among employed patients, 32% (124 out of 387) reported lost hours of work in preceding week because of dyspepsia (absenteeism). The average number of work hours lost due to dyspepsia-related absenteeism was 2.63 Ϯ 6.95 hours per week among all employed patients. The percentage of work missed because of dyspepsia (absenteeism) was 8.12%. Among employed patients, 78% (302 out of 387) report reduced productivity while working, reporting 34.7% less productivity in average, whereas mean presenteeism was 12.1 Ϯ 13.8 hours per week. The lost work productivity score was 35.7% among all employed patients. A summary of the results is shown in Table 2 .
Effects of functional dyspepsia versus organic dyspepsia on productivity
Among employed patients, 30.9% of patients with functional dyspepsia reported absenteeism versus 34% of organic dyspepsia patients (P ϭ 0.609). The mean number of lost hours was 2.34 Ϯ 6.32 per week for patients with functional dyspepsia versus 3.05 Ϯ 7.13 hours per week for patients with organic dyspepsia (P ϭ 0.36). In the same sample, 77% of patients with functional dyspepsia reported presenteeism versus 79.8% of patients with organic dyspepsia (P ϭ 0.77). There were no differences of lost work productivity score between patients with functional and organic dyspepsia (P ϭ 0.41, data not shown).
Correlation of dyspepsia intensity and productivity loss
There was no difference in the proportion of those reporting absenteeism between those with lower and higher PADYQ scores (29.7% vs. 32.7%; P ϭ 0.74), but higher rates of presenteeism was reported by those with higher scores (62.5% vs. 83.2%; P ϭ 0.003). The mean loss of productivity while working was 23.6% versus 37.3%, respectively (P ϭ 0.001). A weak positive linear correlation was noted between dyspepsia score and lost work productivity score, with an r value of 0.21 (P ϭ 0.006).
Monetary value
Considering that the gross domestic product per capita in Brazil crossed the 10,000 dollars/year barrier recently, is estimated that the total productivity impairment (absenteeism ϩ presenteeism) is costing US$3570 annually, or US$297.50 monthly per employed dyspeptic patient. The cost of absenteeism was US$20.97 monthly and the cost of presenteeism US$276.52 monthly ( Table 2) .
Sensitivity analysis
Sensitivity analysis of absenteeism was performed considering the data about absence compensating mechanism reported by Severens et al. [18] . According to this study, 75% of the absenteeism caused by dyspepsia is compensated (mainly by colleagues during normal working hours). The absenteeism cost considering this compensation was calculated to be US$5.24 per month. Because dyspeptia symptoms are intermittent, we performed a conservative sensitivity analysis of presenteeism taking in account that 15% of the time a patient is experiencing dyspepsia. Fifteen percent was chosen because it is the minimum frequency need to fulfill the Rome III criteria for dyspepsia (1 day/week). In this sensitivity analysis, the presenteeism cost is reduced to US$41.48 per month. In this conservative analysis, the total productivity loss due to dyspepsia falls to US$46.72 monthly or 4.95% of total productivity of employees with functional dyspepsia.
Influence of dyspepsia on daily life
Reduced productivity while carrying out daily life activities was also considerable. Overall, 83.8% (729 out of 850) of all patients reported reduced productivity during daily life ( Table 2 ). The mean reduction was 40.5% Ϯ 29.03%. The influence of dyspepsia on daily life was higher among unemployed (43.0% Ϯ 29.5%) compared to employed patients (37.6% Ϯ 26.2%; P ϭ 0.007).
Multivariate analysis
To examine the influence that several potentially important prognostic factors have on absenteeism, presenteeism, or daily life activities, the following factors were first examined individually by univariate analysis: sex, age, race, etiology of dyspepsia (organic or functional), years of education, familiar income, basal PADYQ score (Յ 20 vs. Ͼ 20), type of dyspepsia (ulcer-like or dismotility), coffee and alcohol consumption, smoking, and duration GDP, Gross domestic product. * Sensitivity analysis of absenteeism was performed considering 75% of the absenteeism in dyspepsia is compensated [18] . † Sensitivity analysis of presenteeism was performed considering dyspepsia is intermittent. 
Discussion
This study shows that dyspepsia has a notable affect on work productivity and daily life activities. Our study analysis suggests that each employed person with dyspepsia has lost 35.7% of his or her potential productivity, considering absenteeism and presenteeism. Even the most conservative sensitivity analysis shows a reduction of productivity of 4.95%. In Brazil, the prevalence of dyspepsia symptoms is 40%, accordingly a population-based transversal study [19] . This means that in the best case scenario 1.98% of the national workforce is compromised due to dyspepsia symptoms. The best scenario estimated an effect on the Brazilian gross domestic product of US$30 billion. We also observed a substantial reduction of productivity while carrying out daily life activities. Functional dyspepsia has been neglected, in part, by the absence of associated mortality and absence of financial interests. Our data show that there is no difference between the effects on work productivity of patients with functional or organic dyspepsia. Because functional dyspepsia is three times more prevalent than organic dyspepsia, the lack of attention that functional dyspepsia has received from health authorities is conceivable. In Brazil, there are no clinical protocols of care aimed at the treatment of functional dyspepsia. Furthermore, endoscopic procedures are difficult to access and are low-paying procedures.
Brook et al. [10] showed that employees with functional dyspepsia have an additional 0.83 absence days per year. This value is well below what we found. It is worth considering that the methodology of Brook et al.'s study [10] had sensitivity only to identify full-day absence from work. We believe that patients with symptoms of dyspepsia more often have to leave work early, but hardly need to miss the entire day. Brook et al. [10] also showed a reduced daily productivity of blue-collar workers of 12%. Our study analysis shows a presenteeism of 34%. These two results are comparable. Lerner et al. [20] showed a 2:1 relationship between illnessrelated self-reported productivity loss while at work and objectively measured productivity loss. Furthermore, we believe that the effects of dyspepsia in white-collar workers may be even greater than shown in blue-collar workers because the loss in both ability to focus and creativity are the main complaints reported.
Surprisingly, the loss of productivity in daily activities was higher among unemployed persons. This may mean greater attention to professional activities by those who are employed, or that, for some, the reason for being unemployed may be related to more severe dyspepsia.
Our study has some limitations. Half of patients with dyspepsia had never consulted a doctor, and their symptoms may have less impact on productivity at work than the population studied by us. The WPAI has a visual analogue scale to measure presenteeism and this kind of scale is susceptible to measurement biases such as spacing-out bias and end-aversion bias. Furthermore, Lerner et al. [20] found that for each 10% increase in self-reported work limitation, there is 4% to 5% reduction in objectively measured productivity. The sensitivity analysis we conducted was very conservative and directed precisely to minimize this potential bias. Probably our results underestimate presenteeism because we used the bottom limit of the dyspepsia definition for frequency to perform this calculation, but we deliberately did so to show the financial effects of dyspepsia in an unquestionable manner.
Conclusions
Our study shows that either organic or functional dyspepsia has a large influence on the productivity of Brazilian workers. Cost-effective measures of prevention, investigation, and treatment of dyspepsia should be prioritized in the planning of health care.
